Biorad sec filings

WebApr 13, 2024 · Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) have been assigned an average recommendation of “Buy” from the six research firms that are … WebApr 11, 2024 · Shares of NYSE:BIO opened at $469.95 on Tuesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 4.29 and a current ratio of 5.55. Bio-Rad Laboratories, Inc. has a 52-week low of ...

CENTRAL TRUST Co Cuts Holdings in Bio-Rad Laboratories, Inc.

WebSEC Filing Details. Form 4. 04/11/2024. Statement of Changes in Beneficial Ownership. PDF Format Download (opens in new window) Word Format Download (opens in new … WebLife Science Research. Bio-Rad Products. Genomics; Antibodies; Flow Cytometry; Transfection; Electrophoresis and Blotting; Imaging Systems & Software ; Bio-Plex Multiplex Immunoassay System crystal moore facebook https://retlagroup.com

Latest SEC filings for Bio-Rad Laboratories, Inc. (BIO)

WebDownload Bio-Rad annual reports, SEC filings, and quarterly results. Obtain investor kits, corporate information, and answers to Company and stock FAQs here. http://bioradlab2024tf.q4web.com/sec-filings/sec-filings-details/default.aspx?FilingId=16557312 WebApr 13, 2024 · Vaughan Nelson Investment Management L.P. boosted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Rating) by 202.0% during the 4th quarter, … crystal moore

BIO - Bio-Rad Laboratories Stock SEC Filings - Barchart.com

Category:Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Purchased by …

Tags:Biorad sec filings

Biorad sec filings

Sumitomo Mitsui DS Asset Management Company Ltd Has …

WebFeb 16, 2024 · Current report filing. 04/11/2024. SC 13D/A. Amended Statement of Beneficial Ownership. 04/11/2024. 4. Statement of Changes in Beneficial Ownership. … WebApr 6, 2024 · Bio-Rad Laboratories, Inc. SEC Filing - Quarterly Report (10-Q) October 28, 2024 Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript Bio-Rad Labs …

Biorad sec filings

Did you know?

WebMar 29, 2024 · SEC Filings. Select Year: Filter filing type: Date Filing Type Filing Description Download / View. 02/23/2024. 8-K. Current report filing. 02/17/2024. 10-K. … Bio-Rad is a global leader in developing, manufacturing, and marketing a broad … WebInvestor Relations Financial Reports & SEC Filings Financial Reports. QIAGEN N.V.reports its annual results under U.S. GAAP (SEC filing) due to the listing of our stock at the New York Stock Exchange. As a company established under the laws of The Netherlands we are required by law to also report under IFRS accounting standards.

WebFeb 17, 2024 · HERCULES, Calif.—February 16, 2024 -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, … WebApr 10, 2024 · Sumitomo Mitsui DS Asset Management Company Ltd raised its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 1.7% in the fourth quarter, according to its most recent ...

WebApr 13, 2024 · Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) have been assigned an average recommendation of “Buy” from the six research firms that are currently covering the firm, Marketbeat.com reports.Five investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have … WebFind the latest SEC Filings data for Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) at Nasdaq.com.

WebNov 3, 2014 · The SEC’s order finds that Bio-Rad, headquartered in Hercules, Calif., violated the anti-bribery, internal controls, and books and records provisions of the …

Webassist Bio -Rad Russia in the sale of Bio -Rad products to the Russian government. 8. Bio -Rad Laboratories 6LQJDSRUH 3WH /LPLWHG ³%LR -5DG6LQJDSRUH´ is %LR … dx code for altered bowel functionWebApr 11, 2024 · The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 27.40% of the company's stock. Bio-Rad Laboratories Trading Up 0.8 %. Shares of Bio-Rad Laboratories stock opened at $469.95 on Tuesday. Bio-Rad Laboratories, Inc. has a twelve month low of $344.63 and a twelve … crystal moon sun catcherWebBio-Rad Laboratories (BIO) Alerts Watch Help Go To: SEC Filings Types of filings include: Registration Statement - details of the business and type of investments offered 10-K … dx code for anatomy scanWebSEC Filings for Bio-Rad Laboratories (BIO) including Annual 10-K and Quarterly 10-Q Reports. SEC Filings for Bio-Rad Laboratories (BIO) including Annual 10-K and Quarterly 10-Q Reports. ... SEC Filings are formal documents required by the government that describe the financial health and operating activities for any company that has publicly ... crystal moon witte herderWebApr 11, 2024 · CENTRAL TRUST Co trimmed its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 74.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 135 shares of the medical research company’s stock after … crystal moon lounge corinthiaWebMar 20, 2024 · BIO Bio-Rad Laboratories, Inc.SEC Filings. BIO. Bio-Rad Laboratories, Inc. 7.89K followers. $466.70 -3.17 ( -0.67%) 3:27 PM 03/20/23. NYSE $USD Realtime. … crystal moon gdocWebApr 28, 2024 · Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2024. First-quarter 2024 net sales were $700.1 million, a decrease of 3.7 percent compared to $726.8 million reported for the first quarter of 2024. … crystal moon svg